Table 2:
Prevalence of Posttransplant Metabolic Syndrome (PTMS) and its components.
PTMS
45–58%
Obesity
21–43%
Hypertension
62–69%
Hypertriglyceridemia
66–85%
Low HDL-C
48–52%
Posttransplant
de novo
fatty liver disease
18–40% (100% recurrence in patients transplanted for cryptogenic cirrhosis at 5 years)